OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of Action of the US Food and Drug Administration-Approved Antisense Oligonucleotide Drugs
Angela Sang, S. Zhuo, Adara Bochanis, et al.
BioDrugs (2024) Vol. 38, Iss. 4, pp. 511-526
Closed Access | Times Cited: 6

Showing 6 citing articles:

Impact on efficacy of target reduction of two FDA-approved ASO drugs by intracellular glucose levels in in vitro cell models
Le Tra Giang Nguyen, Sherouk M. Tawfik, Jing Jin, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 1, pp. 102487-102487
Open Access

Consensus guidelines for assessing eligibility of pathogenic DNA variants for antisense oligonucleotide treatments
David Cheerie, Margaret Meserve, Danique Beijer, et al.
The American Journal of Human Genetics (2025)
Open Access

Analysis of Exon Skipping Applicability for Dysferlinopathies
Jamie Leckie, Samantha Rodriguez, Martin Krahn, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 177-177
Open Access

mRNA Degradation as a Therapeutic Solution for Mucopolysaccharidosis Type IIIC: Use of Antisense Oligonucleotides to Promote Downregulation of Heparan Sulfate Synthesis
Juliana Inês Santos, Mariana Gonçalves, Matilde Barbosa Almeida, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1273-1273
Open Access

RNA-based therapies in liver metabolic diseases
Antonio Fontanellas, Pedro Berraondo, F Urigo, et al.
Gut (2025), pp. gutjnl-331742
Open Access

Exploring new therapeutics for Duchenne muscular dystrophy and related cardiomyopathy
Bin Li, Weiyao Xiong, Andrew Chia Hao Chang, et al.
Rare Disease and Orphan Drugs Journal (2025) Vol. 5, Iss. 2
Open Access

Page 1

Scroll to top